Computational and Mathematical Methods in Medicine

Mathematical Modelling and Simulation of Aspects of Cancer Growth


Status
Published

Mathematical Modelling and Simulation of Aspects of Cancer Growth

Articles

  • Special Issue
  • - Volume 4
  • - Article ID 351243

Modelling Tumor Progression, Heterogeneity, and Immune Competition

D. Ambrosi | N. Bellomo | L. Preziosi
  • Special Issue
  • - Volume 4
  • - Article ID 406920

Polymyositis, Topological Proteomics Technology and Paradigm for Cell Invasion Dynamics

Walter Schubert
  • Special Issue
  • - Volume 4
  • - Article ID 306701

A Kinetic Model of Tumor/Immune System Cellular Interactions

Luisa Arlotti | Andrea Gamba | Miroslaw Lachowicz
  • Special Issue
  • - Volume 4
  • - Article ID 190323

Modelling Macrophage Infiltration into Avascular Tumours

C. E. Kelly | R. D. Leek | ... | C. E. Lewis
  • Special Issue
  • - Volume 4
  • - Article ID 162565
  • - Preface

Special Issue on “Mathematical Modelling and Simulation of Aspects of Cancer Growth”

Mark Chaplain
  • Special Issue
  • - Volume 4
  • - Article ID 456976

Marchuk's Model of Immune System Dynamics with Application to Tumour Growth

Urszula Foryś
  • Special Issue
  • - Volume 4
  • - Article ID 179645

Breast Cancer: Modelling and Detection

D. J. Gavaghan | J. M. Brady | ... | P. K. Maini
  • Special Issue
  • - Volume 4
  • - Article ID 396101

Automatic Recognition of Muscle-Invasive T-Lymphocytes Expressing Dipeptidyl-Peptidase IV (CD26) and Analysis of the Associated Cell Surface Phenotypes

W. Schubert | M. Friedenberger | ... | H. Ritter
Computational and Mathematical Methods in Medicine
 Journal metrics
Acceptance rate32%
Submission to final decision46 days
Acceptance to publication39 days
CiteScore3.400
Impact Factor1.770
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.